Skip to content

Clinical observation of the treatment of Parkinson's disease with Fenning prescription

Clinical observation of the treatment of Parkinson's disease with Fenning prescription

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000585
Enrollment
Unknown
Registered
2024-10-21
Start date
2024-10-26
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson disease

Interventions

Chinese medicine group:The control group was given Jianfangning decoction by oral administration
Control group:Conventional western medicine treatment

Sponsors

The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria of TCM and Western medicine for PD; (2) Regardless of gender 40= age =80 years old PD course =6 months; (3) Improved Hoehn-Yahr classification to 1~3; (See Appendix 2) (4) Voluntarily participate in this study and accept relevant examinations and treatment with Fangning prescription; (5) The type and dose of Parkinson's disease treatment drugs remained stable in the past 14 days; (6) Those who agree to sign the informed consent. Note: Patients who meet the above 6 criteria can be included in this study.

Exclusion criteria

Exclusion criteria: (1) Parkinson's syndrome caused by other causes; (2) Have a history of repeated stroke or serious cardiovascular history combined with liver and kidney insufficiency hematopoietic system or coagulation dysfunction; (3) those with drug abuse alcoholism and alcohol dependence; (4) Those who are afraid of oral administration of TCM decoction or are undergoing other clinical trials. Note: Patients who meet any 1 of the above criteria will be excluded.

Design outcomes

Primary

MeasureTime frame
Unified Parkinson's Disease Rating Scale;TCM syndrome score scale;

Secondary

MeasureTime frame
Fecal beta diversity;Relative abundance of fecal flora;Gait analysis;Berg balance scale;Faecal alpha diversity;Standing and walking test;

Countries

China

Contacts

Public ContactJiang Yang

The Affiliated Hospital of Hunan Academy of Traditional Chinese Medicine

340240@hnucm.edu.cn18890366815

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026